Golden Throat Holdings Group Company Limited (6896.HK)
HKD 4.25
(-0.47%)
HKD 4.25
(-0.47%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 697.71 Million CNY | -3.22% |
| 2022 | 720.92 Million CNY | 24.78% |
| 2021 | 577.73 Million CNY | 21.46% |
| 2020 | 475.64 Million CNY | -20.52% |
| 2019 | 598.45 Million CNY | 15.86% |
| 2018 | 516.51 Million CNY | 18.58% |
| 2017 | 435.58 Million CNY | -21.51% |
| 2016 | 554.94 Million CNY | 6.29% |
| 2015 | 522.1 Million CNY | 21.45% |
| 2014 | 429.9 Million CNY | 17.18% |
| 2013 | 366.86 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 335.6 Million CNY | -7.32% |
| 2023 FY | 697.71 Million CNY | -3.22% |
| 2023 Q2 | 362.11 Million CNY | -26.67% |
| 2022 Q4 | 493.85 Million CNY | 117.49% |
| 2022 FY | 720.92 Million CNY | 24.78% |
| 2022 Q2 | 227.06 Million CNY | -24.84% |
| 2021 Q4 | 302.13 Million CNY | 9.62% |
| 2021 Q2 | 275.6 Million CNY | -14.76% |
| 2021 FY | 577.73 Million CNY | 21.46% |
| 2020 Q2 | 152.31 Million CNY | -54.8% |
| 2020 FY | 475.64 Million CNY | -20.52% |
| 2020 Q4 | 323.33 Million CNY | 112.28% |
| 2019 FY | 598.45 Million CNY | 15.86% |
| 2019 Q4 | 336.96 Million CNY | 28.86% |
| 2019 Q2 | 261.49 Million CNY | -13.99% |
| 2018 Q4 | 304.02 Million CNY | 43.07% |
| 2018 FY | 516.51 Million CNY | 18.58% |
| 2018 Q2 | 212.49 Million CNY | -21.07% |
| 2017 Q4 | 269.22 Million CNY | 61.82% |
| 2017 FY | 435.58 Million CNY | -21.51% |
| 2017 Q2 | 166.36 Million CNY | -43.9% |
| 2016 Q4 | 296.55 Million CNY | 14.78% |
| 2016 Q2 | 258.38 Million CNY | -4.09% |
| 2016 FY | 554.94 Million CNY | 6.29% |
| 2015 Q4 | 269.39 Million CNY | 6.6% |
| 2015 Q2 | 252.71 Million CNY | 12.97% |
| 2015 FY | 522.1 Million CNY | 21.45% |
| 2014 Q2 | 206.21 Million CNY | 91.87% |
| 2014 Q4 | 223.69 Million CNY | 8.48% |
| 2014 FY | 429.9 Million CNY | 17.18% |
| 2013 Q4 | 107.47 Million CNY | 0.0% |
| 2013 FY | 366.86 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -316.708% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 89.305% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -2324.403% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -76.721% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 2059.72% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -26.556% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 54.673% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -48.044% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -222.08% |
| SSY Group Limited | 3.48 Billion HKD | 80.003% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -118.436% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -12.449% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 98.391% |